您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (12): 19-25.doi: 10.6040/j.issn.1671-7554.0.2022.0976

• 临床医学 • 上一篇    

超低频经颅磁刺激对帕金森病睡眠障碍患者的疗效观察

田祥奇,王皓,徐新荣,方雨晴,毛飞,赵张宁,赵海龙,吴丙云,李秀华   

  1. 山东第一医科大学第一附属医院(山东省千佛山医院)神经病学, 山东省神经免疫研究所, 山东省风湿免疫病转化医学重点实验室, 山东 济南250014
  • 发布日期:2022-12-01
  • 通讯作者: 李秀华. E-mail:1xh731023@126.com
  • 基金资助:
    济南市临床医学科技创新计划(202019111)

Efficacy of ultra-low frequency transcranial magnetic stimulation in patients with Parkinsons disease sleep disorders

TIAN Xiangqi, WANG Hao, XU Xinrong, FANG Yuqing, MAO Fei, ZHAO Zhangning, ZHAO Hailong, WU Bingyun, LI Xiuhua   

  1. Department of Neurology, The First Affiliated Hospital of Shandong First Medical University &
    Shandong Provincial Qianfoshan Hospital, Shandong Institute of Neuroimmunology, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan 250014, Shandong, China
  • Published:2022-12-01

摘要: 目的 观察超低频经颅磁刺激(ULF-TMS)治疗帕金森病睡眠障碍(PDSD)患者的疗效,探讨ULF-TMS改善PDSD的可能机制。 方法 选取PDSD患者90例,按随机数字表法分为γ-氨基丁酸(GABA)组、5-羟色胺(5-HT)组和对照组,每组30例。GABA组给予GABA特征磁刺激治疗,5-HT组给予5-HT特征磁刺激治疗,对照组给予假刺激治疗,1次/d,治疗时间为35 min/次,连续治疗7 d。所有患者均常规服用抗帕金森药物。分别监测各组患者治疗前1 d、治疗结束第1天、治疗结束第30天匹兹堡睡眠质量指数量表(PSQI)、帕金森病睡眠量表(PDSS)、Epworth嗜睡量表(ESS)、汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)评分变化。 结果 重复测量方差分析结果显示:在治疗前1 d、治疗结束第1天、治疗结束第30天各组患者PSQI、PDSS、ESS、HAMD、HAMA评分的时点因素、时点和组别交互作用均差异有统计学意义(P<0.001),组别因素差异无统计学意义(P>0.05)。进一步两两比较结果显示:与同组治疗前1 d相比,GABA组和5-HT组患者治疗结束第1天 PSQI、ESS、HAMD、HAMA评分均降低(P<0.05),PDSS评分均升高(P<0.05),各组患者治疗结束第30天 PSQI、PDSS、ESS、HAMD、HAMA评分与同组治疗前1 d相比较均差异无统计学意义(P>0.05)。各组患者治疗结束第1天PSQI、ESS、HAMD、HAMA评分相比较,GABA组和5-HT组均低于对照组(P<0.05),各组治疗结束第1天PDSS评分比较,GABA组和5-HT组均高于对照组(P<0.05),治疗结束第30天各组PSQI、PDSS、ESS、HAMD、HAMA评分两两间比较均差异无统计学意义(P>0.05)。 结论 超低频经颅磁刺激可以短期改善PDSD患者的睡眠质量及情绪障碍。

关键词: 超低频经颅磁刺激, 帕金森病, 睡眠障碍, γ-氨基丁酸, 5-羟色胺, 情绪障碍

Abstract: Objective To observe the efficacy of ultra-low frequency transcranial magnetic stimulation(ULF-TMS)in the treatment of patients with Parkinsons disease sleep disorder(PDSD), and to explore the possible mechanism. Methods A total of 90 PDSD patients were randomly divided into gamma aminobutyric acid(GABA)group, 5-hydroxytryptamine(5-HT)group and control group, with 30 cases in each group, receiving GABA characteristic magnetic stimulation, 5-HT characteristic magnetic stimulation and sham stimulation, respectively, once a day for 35 minutes for 7 days. All patients routinely took anti-Parkinson drugs. The scores of Pittsburgh Sleep Quality Index(PSQI), Parkinsons Disease Sleep Scale(PDSS), Epworth Sleepiness Scale(ESS), Hamilton Depression Scale(HAMD)and Hamilton Anxiety Scale(HAMA)were monitored 1 day before treatment, 1 day and 30 days after treatment. Results There were significant differences in the time point factors, time point and group interaction of PSQI, PDSS, ESS, HAMD and HAMA scores at the three time points(P<0.001), but there were no significant differences in group factors(P>0.05). Pairwise comparison showed that in the same group, the scores of PSQI, ESS, HAMD and HAMA in the GABA and 5-HT groups decreased(P<0.05), while PDSS score increased(P<0.05)on the day 1 after treatment compared with those 1 day before treatment, but there were no significant differences in PSQI, PDSS, ESS, HAMD and HAMA scores 1 day before treatment and 30 days after treatment(P>0.05). The scores of PSQI, ESS, HAMD and HAMA in GABA and 5-HT groups were lower than those in the control group on day 1 after treatment(P<0.05), while the score of PDSS were higher(P<0.05). The scores of PSQI, PDSS, ESS, HAMD and HAMA were not significantly different 30 days after treatment(P>0.05). Conclusion ULF-TMS can improve sleep quality and mood disorder in PDSD patients in the short term.

Key words: Ultra-low frequency transcranial magnetic stimulation, Parkinsons disease, Sleep disorder, Gamma aminobutyric acid, 5-hydroxytryptamine, Mood disorder

中图分类号: 

  • R574
[1] 中国医师协会神经内科医师分会, 中华医学会神经病学分会帕金森病及运动障碍学组,王丽娟, 等. 中国帕金森病重复经颅磁刺激治疗指南[J]. 中国神经精神疾病杂志, 2021, 47(10): 577-585. Neurophysicians Branch of Chinese Medical Association, Parkinsons Disease and Motor Disorders Group of Neurology Branch of Chinese Medical Association, WANG Lijuan, et al. Chinese guidelines for repeated transcranial magnetic stimulation in Parkinsons disease [J]. Chinese Journal of Nervous and Mental Diseases, 2021, 47(10): 577-585.
[2] Song P, Lin H, Li S, et al. Repetitive transcranial magnetic stimulation(rTMS)modulates time-varying electroencephalography(EEG)network in primary insomnia patients: a TMS-EEG study [J]. Sleep Med, 2019, 56: 157-163. doi: 10.1016/j.sleep.2019.01.007.
[3] Wu H, Lv J, Liu M, et al. The long-term effect of repetitive transcranial magnetic stimulation in the treatment of intractable insomnia [J]. Sleep Med, 2021, 85: 309-312. doi: 10.1016/j.sleep.2021.07.018.
[4] 徐建兰, 徐晓雪, 蔡青, 等. 连续多次γ-氨基丁酸和多巴胺特征重复超低频经颅磁刺激对大鼠脑内神经递质功率的影响[J]. 中国康复医学杂志, 2010, 25(2): 127-130. XU Jianlan, XU Xiaoxue, CAI Qing, et al. Effects of gamma aminobutyric acid and dopamine characteristic repetitive ultra-low frequency transcranial magnetic stimulations on rats neurotransmitter neurotransmitter power [J]. Chinese Journal of Rehabilitation Medicine, 2010, 25(2): 127-130.
[5] Chung S, Weber F, Zhong P, et al. Identification of preoptic sleep neurons using retrograde labelling and gene profiling [J]. Nature, 2017, 545(7655): 477-481.
[6] Chahine LM, Amara AW, Videnovic A. A systematic review of the literature on disorders of sleep and wakefulness in Parkinsons disease from 2005 to 2015 [J]. Sleep Med Rev, 2017, 35: 33-50. doi: 10.1016/j.smrv.2016.08.001.
[7] Hsiao YH, Chen YT, Tseng CM, et al. Sleep disorders and an increased risk of Parkinsons disease in individuals with non-apnea sleep disorders: a population-based cohort study [J]. J Sleep Res, 2017, 26(5): 623-628.
[8] 刘运洲, 张忠秋. 低频重复经颅磁刺激提高运动员睡眠质量的应用研究[J]. 中国运动医学杂志, 2012, 31(12): 1103-1106. LIU Yunzhou, ZHANG Zhongqiu. Effects of low frequency repetitive transcranial magnetic stimulation on sleep quality in athletes [J]. Chinese Journal of Sports Medicine, 2012, 31(12): 1103-1106.
[9] Falup-Pecurariu C, Diaconu ?瘙塁, ?瘙塃în?瘙塅 D, et al. Neurobiology of sleep(review)[J]. Exp Ther Med, 2021, 21(3): 272.
[10] Wilson H, Giordano B, Turkheimer FE, et al. Serotonergic dysregulation is linked to sleep problems in Parkinsons disease [J]. Neuroimage Clin, 2018, 18: 630-637. doi: 10.1016/j.nicl.2018.03.001.
[11] Feng J, Zhang Q, Zhang C, et al. The Effect of sequential bilateral low-frequency rTMS over dorsolateral prefrontal cortex on serum level of BDNF and GABA in patients with primary insomnia [J]. Brain Behav, 2019, 9(2): e01206.
[12] Jones BE. Arousal and sleep circuits [J]. Neuropsychopharmacology, 2020, 45(1): 6-20.
[13] Fort P, Bassetti CL, Luppi PH. Alternating vigilance states: new insights regarding neuronal networks and mechanisms [J]. Eur J Neurosci, 2009, 29(9): 1741-1753.
[14] 邵银进, 李海粟, 吴桂华. 超低频经颅磁刺激治疗慢性失眠的疗效[J]. 实用临床医学, 2018, 19(3): 27-29. SHAO Yinjin, LI Haisu, WU Guihua. Effects of ultra-low frequency transcranial magnetic stimulation on chronic insomnia [J]. Practical Clinical Medicine, 2018, 19(3): 27-29.
[15] Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle [J]. J Neurosci, 1981, 1(8): 876-886.
[16] Wallman MJ, Gagnon D, Parent M. Serotonin innervation of human basal Ganglia [J]. Eur J Neurosci, 2011, 33(8): 1519-1532.
[17] Oikonomou G, Altermatt M, Zhang RW, et al. The serotonergic raphe promote sleep in zebrafish and mice [J]. Neuron, 2019, 103(4): 686-701.
[18] Xia M, Li Z, Li S, et al. Sleep deprivation selectively down-regulates astrocytic 5-HT2B receptors and triggers depressive-like behaviors via stimulating P2X7 receptors in mice [J]. Neurosci Bull, 2020, 36(11): 1259-1270.
[19] Keck ME, Sillaber I, Ebner K, et al. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain [J]. Eur J Neurosci, 2000, 12(10): 3713-3720.
[20] Wilson H, Giordano B, Turkheimer FE, et al. Serotonergic dysregulation is linked to sleep problems in Parkinsons disease [J]. Neuroimage Clin, 2018, 18: 630-637. doi:10.1016/j.nicl.2018.03.001.
[21] Neikrug AB, Avanzino JA, Liu L, et al. Parkinsons disease and REM sleep behavior disorder result in increased non-motor symptoms [J]. Sleep Med, 2014, 15(8): 959-966.
[22] Zhu K, van Hilten JJ, Marinus J. The course of insomnia in Parkinsons disease [J]. Parkinsonism Relat Disord, 2016, 33: 51-57. doi: 10.1016/j.parkreldis.2016.09.010.
[23] Schür RR, Draisma LW, Wijnen JP, et al. Brain GABA levels across psychiatric disorders: a systematic literature review and meta-analysis of(1)H-MRS studies [J]. Hum Brain Mapp, 2016, 37(9): 3337-3352.
[24] Benson C, Mifflin K, Kerr B, et al. Biogenic amines and the amino acids GABA and glutamate: relationships with pain and depression [J]. Mod Trends Pharmacopsychiatry, 2015, 30: 67-79. doi:10.1159/000435933.
[25] 孙元锋, 李哲, 李韵, 等. 超低频经颅磁刺激治疗失眠症患者的疗效[J]. 实用医学杂志, 2013, 29(13): 2168-2169. SUN Yuanfeng, LI Zhe, LI Yun, et al. Effect of ultra-low frequency transcranial magnetic stimulation on insomnia patients [J]. The Journal of Practical Medicine, 2013, 29(13): 2168-2169.
[26] Baeken C, Lefaucheur JP, Van Schuerbeek P. The impact of accelerated high frequency rTMS on brain neurochemicals in treatment-resistant depression: insights from 1H MR spectroscopy [J]. Clin Neurophysiol, 2017, 128(9): 1664-1672.
[27] Ma H, Lin J, He J, et al. Effectiveness of TES and rTMS for the treatment of insomnia: meta-analysis and meta-regression of randomized sham-controlled trials [J]. Front Psychiatry, 2021, 12: 744475. doi: 10.3389/fpsyt.2021.744475.
[1] 张秀芳,李沛铮,张博涵,孙丛丛,刘艺鸣. 生长分化因子15在LPS诱导的帕金森病模型中的保护作用及机制[J]. 山东大学学报 (医学版), 2022, 60(5): 1-7.
[2] 赵海龙,王皓,方雨晴,毛飞,赵张宁,田祥奇,徐新荣,王敏,李秀华. 增服艾地苯醌对34例帕金森病抑郁患者的疗效观察[J]. 山东大学学报 (医学版), 2022, 60(4): 38-44.
[3] 刘丽雯,马俊,李沛铮,张秀芳,刘艺鸣. 128例帕金森病照料者负担及影响因素[J]. 山东大学学报 (医学版), 2022, 60(4): 45-49.
[4] 赵璇,李晓鹏,李剑,田彬,王广君. 磁珠耳穴贴压联合重复经颅磁刺激对脑卒中后抑郁的疗效[J]. 山东大学学报 (医学版), 2022, 60(1): 65-70.
[5] 李湘青,殷欣,赵雪莲,赵培庆. NK细胞亚群CD56bright在帕金森患者外周血中的表达及临床意义[J]. 山东大学学报 (医学版), 2021, 59(2): 34-40.
[6] 徐小明,曾琪,操军,陈小容,吕臻,王我,艾明,孔裔婷,况利. 大一女生自伤行为与心理-社会-基因多态性的关联分析[J]. 山东大学学报 (医学版), 2021, 59(11): 84-92.
[7] 张晓韬,何天齐,朱梅佳,唐吉友,赵张宁,毛飞,方雨晴,刘小民,马高亭,张小雨,张霄,王敏,李秀华. 艾地苯醌联合治疗帕金森病疗效的临床观察[J]. 山东大学学报 (医学版), 2019, 57(4): 34-41.
[8] 郭配,李秀华,张晓韬,何天齐,朱梅佳,唐吉友,赵张宁,毛飞. 伴有睡眠障碍帕金森病患者的睡眠特征及其影响因素[J]. 山东大学学报 (医学版), 2018, 56(4): 76-80.
[9] 勾云, 周波, 魏操,陈运华, 徐利,刘芬, 张春林, 文敏. 硫辛酸对帕金森病大鼠黑质线粒体的保护作用[J]. 山东大学学报(医学版), 2017, 55(8): 18-23.
[10] 崔萌,郑冀鲁,田思男,李连军,张琦,金讯波,王慕文. 前列腺绿激光汽化术治疗良性前列腺梗阻伴帕金森病的疗效[J]. 山东大学学报(医学版), 2017, 55(7): 100-102.
[11] 张文君,沈遥遥,戴庭敏,柴艺轩,涂江龙. 帕金森病并发喉痉挛1例[J]. 山东大学学报(医学版), 2017, 55(5): 125-126.
[12] 马翔宇,李卫国,陈思,陈腾,李超,徐硕,徐淑军,李新钢. 山东大学齐鲁医院神经外科脑深部电刺激术手术步骤标准化操作流程(SOP)暨核查表[J]. 山东大学学报(医学版), 2017, 55(5): 117-121.
[13] 王思,李秀华,杜鹃,岳龙涛,王瑶,刘菲,郭配. 侧脑室注射腺病毒介导的GDNF基因对帕金森病的保护作用[J]. 山东大学学报(医学版), 2016, 54(4): 32-36.
[14] 杨璐, 周英泽, 倪明, 樊秀双, 满建梅, 郭军堂. β-synuclein对Ⅱ型囊泡单胺转移体表达的促进作用[J]. 山东大学学报(医学版), 2015, 53(4): 61-64.
[15] 陈思, 王牧川, 任楠楠, 许巍, 王玲玲, 栾海辉, 马俊, 刘艺鸣. Parkin基因多态性与山东省汉族帕金森病发病风险的关系[J]. 山东大学学报(医学版), 2015, 53(4): 71-74.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!